Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Completed · Phase 1/Phase 2

Conditions studied: Colorectal Cancer, Colon Cancer, Rectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma, Colorectal Tumor

In brief

The purpose of this trial is to determine the safety of 90Y-hMN14 at different dose levels in the treatment of colorectal cancer.

Key facts

Study ID

NCT00040599

Run by

Gilead Sciences

People needed

72

Starts

2000-01-01

Expected to finish

2004-01-01

Last updated by the study team

2021-08-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Hoag Cancer Center — Newport Beach, California, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Bay Pines VA Medical Center — St. Petersburg, Florida, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
• Virginia Mason Medical Center — Seattle, Washington, United States
• Zentralklinik Bad Berka — Bad Berka, Germany
• University Hospital Dresden — Dresden, Germany
• University of Szeged Medical Center — Szeged, Hungary
• Uppsala University Hospital — Uppsala, Sweden
• Centre Pluridisciplinaire d'Oncologie — Lausanne, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.